USE OF PROSTATE-SPECIFIC ANTIGEN, CLINICAL STAGE AND GLEASON SCORE TO PREDICT PATHOLOGICAL STAGE IN MEN WITH LOCALIZED PROSTATE-CANCER - REPLY

被引：0
|
作者：
PARTIN, AW
YOO, J
CARTER, HB
PEARSON, JD
CHAN, DW
EPSTEIN, JI
WALSH, PC
机构：
来源：
JOURNAL OF UROLOGY | 1993年 / 150卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1924 / 1924
页数：1
相关论文
共 50 条
  • [21] DOES PROSTATE-SPECIFIC ANTIGEN ALLOW THE DETERMINATION OF TUMOR STAGE IN PROSTATE-CANCER
    SEMJONOW, A
    HERTLE, L
    UROLOGE A, 1995, 34 (04): : 290 - 296
  • [22] Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer
    Thiel, R
    Pearson, JD
    Epstein, JI
    Walsh, PC
    Carter, HB
    UROLOGY, 1997, 49 (05) : 716 - 720
  • [23] COMBINING PROSTATE-SPECIFIC ANTIGEN WITH CANCER AND GLAND VOLUME TO PREDICT MORE RELIABLY PATHOLOGICAL STAGE - THE INFLUENCE OF PROSTATE-SPECIFIC ANTIGEN CANCER DENSITY
    BLACKWELL, KL
    BOSTWICK, DG
    MYERS, RP
    ZINCKE, H
    OESTERLING, JE
    JOURNAL OF UROLOGY, 1994, 151 (06): : 1565 - 1570
  • [24] PROSTATE-SPECIFIC ANTIGEN AND PROSTATE-CANCER
    GUILLET, J
    ROLE, C
    DUC, AT
    PALU, M
    SENS, A
    FRANCOIS, H
    JOURNAL DE BIOPHYSIQUE ET DE BIOMECANIQUE, 1987, 11 (03): : 124 - 124
  • [25] The association of the phosphatidylinositol-3-kinase pathway to Gleason Score, prostate-specific antigen and pathologic stage in prostate cancer
    Gottschalk, AR
    Weinberg, V
    Carroll, P
    Simko, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S474 - S474
  • [26] Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer
    William D. Figg
    Michael E. Franks
    David Venzon
    Paul Duray
    Michael C. Cox
    W. Marston Linehan
    W. Van Bingham
    James A. Eastham
    Eddie Reed
    Oliver Sartor
    World Journal of Urology, 2004, 22 : 425 - 430
  • [27] A comparison of the Gleason score and clinical stage preoperatively with the Gleason score and pathological stage postoperatively in patients with relapsed prostate cancer
    Kechagioglou, P.
    Ioannidou, G.
    Georgakopoulos, I.
    Alexopoulou, E.
    Katsilieris, I.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 112 - 112
  • [28] Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer
    Figg, WD
    Franks, ME
    Venzon, D
    Duray, P
    Cox, MC
    Linehan, WM
    Van Bingham, W
    Eastham, JA
    Reed, E
    Sartor, O
    WORLD JOURNAL OF UROLOGY, 2004, 22 (06) : 425 - 430
  • [29] Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer
    Spencer, JA
    Chng, WJ
    Hudson, E
    Boon, AP
    Whelan, P
    BRITISH JOURNAL OF RADIOLOGY, 1998, 71 (851): : 1130 - 1135
  • [30] PROSTATE-SPECIFIC ANTIGEN - ITS CLINICAL USE AND APPLICATION IN SCREENING FOR PROSTATE-CANCER
    BANGMA, CH
    BLIJENBERG, BG
    SCHRODER, FH
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1995, 55 : 35 - 44
12345